Home Applications 019389 Application 019389
Type NDA
Sponsor GLAXOSMITHKLINE Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 BECONASE AQ BECLOMETHASONE DIPROPIONATE MONOHYDRATE SPRAY, METERED;NASAL EQ 0.042MG DIPROP/SPRAY Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N019389-001 BECONASE AQ BECLOMETHASONE DIPROPIONATE MONOHYDRATE EQ 0.042MG DIPROP/SPRAY SPRAY, METERED / NASAL RLD 1987-07-27
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 N019389-001 BECONASE AQ EQ 0.042MG DIPROP/SPRAY SPRAY, METERED / NASAL RLD, RS 1987-07-27 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N019389-001 BECONASE AQ EQ 0.042MG DIPROP/SPRAY SPRAY, METERED / NASAL RLD, RS 1987-07-27 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N019389-001 BECONASE AQ EQ 0.042MG DIPROP/SPRAY SPRAY, METERED / NASAL RLD, RS 1987-07-27 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N019389-001 BECONASE AQ EQ 0.042MG DIPROP/SPRAY SPRAY, METERED / NASAL RLD 1987-07-27 a50c72e98297…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 6 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0173-0388 BECONASE beclomethasone dipropionate monohydrate GlaxoSmithKline LLC NDA Current 0173-0388 BECONASE beclomethasone dipropionate monohydrate GlaxoSmithKline LLC NDA Current 0173-0388 BECONASE beclomethasone dipropionate monohydrate GlaxoSmithKline LLC NDA Current 0173-0388 BECONASE beclomethasone dipropionate monohydrate GlaxoSmithKline LLC NDA Current 0173-0388 BECONASE beclomethasone dipropionate monohydrate GlaxoSmithKline LLC NDA Current 0173-0388 BECONASE beclomethasone dipropionate monohydrate GlaxoSmithKline LLC NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 58349 SUPPL 2019-04-18 58329 SUPPL 2019-04-15 33736 SUPPL 2005-11-01 1313 SUPPL 2005-11-01 33735 SUPPL 2003-04-15 17384 SUPPL 2002-12-19 17385 SUPPL 2002-12-16